Optimization of an Oncolytic HSV-1 for the Treatment of Glioblastoma

Time: 3:10 pm
day: Day Two

Details:

  • Optimization of oHSV backbone 7 Transgenes
  • Development of clinical candidate oncolytic virus

Speakers:

Christophe Queva
Christophe Queva

Read more